| Original language | English (US) |
|---|---|
| Pages (from-to) | 569-578 |
| Number of pages | 10 |
| Journal | Medical mycology |
| Volume | 58 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 23 2019 |
Bibliographical note
Funding Information:M.M. reports research support and consulting fees from Astellas and Scynexis L.O.Z. has received research, consulting, and/or speaking funds from the following companies: Pfizer, Astellas, Scynexis, Cidara, Amplyx, F2G, Gilead, Viracor, and RealTime.
Funding Information:
G.R.T. reports research support and serving as a consultant for Am-plyx, Cidara, Scynexis, Mayne, F2G, Pfizer. S.C. reports educational grants from Merck.
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS